Publications by authors named "A Kampmann"
Article Synopsis
- Telangiectasia is a key feature of rosacea, necessitating effective treatment and standardized assessment tools for clinical evaluations.
- The study aimed to create and validate the TRoSA scale, a five-point photonumeric system to evaluate telangiectasia severity in rosacea patients, using feedback from 16 experts and 50 patient images.
- Results showed that the TRoSA scale has high interrater and intrarater reliability, making it a reliable tool for consistent clinical assessments and treatment evaluations in rosacea.
The Eustachian tube (ET) is a bottleneck when it comes to middle ear (ME) health. If its function is impaired, this can lead to serious consequences for the patient, such as hearing problems or deafness. Therefore, this study investigated a tapered nitinol stent (3-5 mm × 14 mm) for the human ET as a potential new permanent treatment for chronic Eustachian tube dysfunction (ETD) and thus ME ventilation disorders.
View Article and Find Full Text PDFObjectives: Bisphosphonates are known to induce a severe adverse effect known as medication-related osteonecrosis of the jaw (MRONJ). Previous studies have proven the impact of bisphosphonates on microperfusion; therefore, this study aimed to investigate alendronate-induced microcirculatory reactions in the calvarial periosteum of rats.
Study Design: Bone chambers were implanted into 48 Lewis rats.
The musculoskeletal system consists of different components comprising a wide range of tissue types, with tendons being one part. Tendon degeneration or rupture have a high prevalence in all age groups, often with poor outcomes of surgical treatment such as chronic pain and high re-tear rates. Therefore, much effort has been directed to further develop diagnostic and therapeutic methods as well as reconstruction techniques, including using adequate placeholders or implants.
View Article and Find Full Text PDFSuitability of CD133 as a Marker for Cancer Stem Cells in Melanoma.
Asian Pac J Cancer Prev
May 2021
Objectives: CD133 is considered a cancer stem cell (CSC) marker in various malignancies; however, its role as a biomarker of malignant melanoma remains controversial. The present study was conducted to evaluate the suitability of CD133 surface antigen as a CSC marker in melanoma.
Methods: Human melanoma cells were fractionally separated by magnetic cell separation depending on the CD133 phenotype and transplanted into immunodeficient mice to evaluate their tumorigenic capacity.